Literature DB >> 20586434

NovoFLAP: A ligand-based de novo design approach for the generation of medicinally relevant ideas.

James R Damewood1, Charles L Lerman, Brian B Masek.   

Abstract

NovoFLAP is a computer-aided de novo design tool that generates medicinally relevant ideas for ligand-based projects. The approach combines an evolutionary algorithm (EA-Inventor) with a powerful ligand-based scoring function that uses both molecular shape and pharmacophore features in a multiconformational context (FLAP). We demonstrate that NovoFLAP can generate novel ideas that are not only appealing to design scientists but are also validated by comparison to compounds known to demonstrate activity at the desired biological target. NovoFLAP provides a novel computer-aided design technique that can be used to generate ideas that maintain desirable molecular attributes, such as activity at the primary biological target, while offering opportunities to surmount additional design challenges. Application to the design of the first nonbasic 5HT(1B) antagonist is presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586434     DOI: 10.1021/ci100080r

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  De novo design by pharmacophore-based searches in fragment spaces.

Authors:  Tobias Lippert; Tanja Schulz-Gasch; Olivier Roche; Wolfgang Guba; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2011-09-16       Impact factor: 3.686

Review 2.  Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications.

Authors:  Yuemin Bian; Xiang-Qun Sean Xie
Journal:  AAPS J       Date:  2018-04-09       Impact factor: 4.009

3.  Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization.

Authors:  Rajnish Kumar; Bengt Långström; Taher Darreh-Shori
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.